These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17458190)

  • 21. Arteries, inflammation and insulin resistance.
    Amar J; Perez L; Burcelin R; Chamontin B
    J Hypertens Suppl; 2006 Aug; 24(5):S18-20. PubMed ID: 16936531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The roles of adipokines in the regulation of insulin sensitivity].
    Yamauchi T; Kadowaki T
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():132-8. PubMed ID: 17458207
    [No Abstract]   [Full Text] [Related]  

  • 23. Sleep and the metabolic syndrome.
    Wolk R; Somers VK
    Exp Physiol; 2007 Jan; 92(1):67-78. PubMed ID: 17085678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of insulin resistance and associated diseases.
    Mlinar B; Marc J; Janez A; Pfeifer M
    Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary and lifestyle interventions in the management of the metabolic syndrome: present status and future perspective.
    Minehira K; Tappy L
    Eur J Clin Nutr; 2002 Dec; 56(12):7 p following 1262. PubMed ID: 12494312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature.
    Türkoglu C; Duman BS; Günay D; Cagatay P; Ozcan R; Büyükdevrim AS
    Obes Surg; 2003 Oct; 13(5):699-705. PubMed ID: 14627463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic syndrome--from insulin resistance to obesity and diabetes.
    Gallagher EJ; LeRoith D; Karnieli E
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):559-79, vii. PubMed ID: 18775352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of OSA with insulin resistance, inflammation and metabolic syndrome.
    Peled N; Kassirer M; Shitrit D; Kogan Y; Shlomi D; Berliner AS; Kramer MR
    Respir Med; 2007 Aug; 101(8):1696-701. PubMed ID: 17466499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased high-molecular weight adiponectin-to-total adiponectin ratio in sera is associated with insulin resistance in Japanese metabolically obese, normal-weight men with normal glucose tolerance.
    Katsuki A; Suematsu M; Gabazza EC; Murashima S; Nakatani K; Togashi K; Yano Y; Sumida Y
    Diabetes Care; 2006 Oct; 29(10):2327-8. PubMed ID: 17003319
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of stress in the pathogenesis of the metabolic syndrome.
    Rosmond R
    Psychoneuroendocrinology; 2005 Jan; 30(1):1-10. PubMed ID: 15358437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity; epiphenomenon or cause of metabolic syndrome?
    Lois K; Young J; Kumar S
    Int J Clin Pract; 2008 Jun; 62(6):932-8. PubMed ID: 18479286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
    Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
    Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease and metabolic syndrome: a concise review.
    Streba LA; Cârstea D; Mitruţ P; Vere CC; Dragomir N; Streba CT
    Rom J Morphol Embryol; 2008; 49(1):13-20. PubMed ID: 18273497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome.
    Chang CJ; Yang YC; Lu FH; Lin TS; Chen JJ; Yeh TL; Wu CH; Wu JS
    Am J Med; 2010 May; 123(5):432-8. PubMed ID: 20399320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance, metabolic syndrome and endothelial dysfunction.
    Bigazzi R; Bianchi S
    J Nephrol; 2007; 20(1):10-4. PubMed ID: 17347967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance in obesity as the underlying cause for the metabolic syndrome.
    Gallagher EJ; Leroith D; Karnieli E
    Mt Sinai J Med; 2010; 77(5):511-23. PubMed ID: 20960553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk.
    Bergman RN; Kim SP; Hsu IR; Catalano KJ; Chiu JD; Kabir M; Richey JM; Ader M
    Am J Med; 2007 Feb; 120(2 Suppl 1):S3-8; discussion S29-32. PubMed ID: 17296343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin and insulin sensitivity in primary aldosteronism.
    Fallo F; Della Mea P; Sonino N; Bertello C; Ermani M; Vettor R; Veglio F; Mulatero P
    Am J Hypertens; 2007 Aug; 20(8):855-61. PubMed ID: 17679033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiology patient page. The metabolic syndrome.
    Lennie TA
    Circulation; 2006 Oct; 114(15):e528-9. PubMed ID: 17030691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.